35.2 million cash end of June 2023 + 6.6 million Mundipharma cash + 7.6 million R&D = 49.8 million
Minus 10 million to December 2023 quarter
Minus 5 million in loans
We should have access to 35 million (includes net $2 million R&D due Financial year 2024
Our net cash position should be around 35 million December quarter 2023
This will not include any milestone payments and cash revenue from licensed products and any upfront fees from licensees
No need for any capital raising any time soon
- Forums
- ASX - By Stock
- SPL
- Ann: App 4E/Annual Report to shareholders
Ann: App 4E/Annual Report to shareholders, page-16
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.4¢ | 9.4¢ | 9.4¢ | $481 | 5.115K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 249999 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 249999 | 0.093 |
1 | 50000 | 0.091 |
2 | 20900 | 0.090 |
2 | 147200 | 0.087 |
1 | 6395 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 65000 | 1 |
0.099 | 49985 | 2 |
0.100 | 111205 | 3 |
0.105 | 66531 | 4 |
0.110 | 13099 | 5 |
Last trade - 11.47am 09/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |